Skip to content

Thomas J. Connor

4 papers in the library · 143 citations · publishing 2001-2010

Papers

Sort Most recent Most cited

Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?

British Journal of Pharmacology May 27, 2010 Noreen T. Boyle, Thomas J. Connor 42 citations

Methylenedioxymethamphetamine (MDMA; 'Ecstasy') is a ring-substituted amphetamine and a popular drug of abuse. In addition to ability to induce euphoria, MDMA abuse is associated with a range of acute and long-term hazardous effects. This paper is focused on once such adverse effect: its ability to negatively impact on functioning of the immune system. Research demonstrates that MDMA has...

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

Immunology March 30, 2004 Thomas J. Connor 101 citations

Summary Drug abuse is a global problem of considerable concern to health. One such health concern stems from the fact that many drugs of abuse have immunosuppressive actions and consequently have the potential to increase susceptibility to infectious disease. This article is focused on the impact of the amphetamine derivative, methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) on immunity....

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.

European Journal of Neuroscience August 2003 Andrew Harkin, Eamonn Shanahan, John P Kelly et al.

The effect of prior exposure to methylenedioxyamphetamine (MDA) on behavioural and neurochemical responses to fluoxetine were assessed in a rat model of antidepressant action. MDA (7.5 mg/kg, i.p.) was administered to rats twice daily for 4 consecutive days, and 4 weeks later the behavioural effect of fluoxetine (5 or 20 mg/kg; i.p. x 3) was examined in the modified rat forced-swimming test. In...

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.

Life Sciences February 9, 2001 Andrew Harkin, Thomas J. Connor, J Mulrooney et al.

The substituted amphetamine 3,4 methylenedioxyamphetamine (MDA) is a popular recreational drug of abuse. Administration of MDA to experimental animals has been shown to induce damage to serotonergic axons and nerve terminals. However, there is a lack of information on whether these treatments can produce any long-term changes in behavioural performance particularly under stressful conditions....